emily chan

Hach shows age not always a barrier to cancer therapy

Phila Hach recently celebrated her 89th birthday and she has had much to celebrate over the years.

model of DNA double helix

New type of trial shows promise for several cancers

Anti-cancer drugs are typically tested on one type of cancer at a time. But an international consortium of cancer investigators, including Vanderbilt-Ingram Cancer Center (VICC) researchers, simultaneously tested an existing therapy in patients with several different forms of cancer that all exhibit the same tumor gene mutation.

VICC adds colon cancer to gene mutation testing

Vanderbilt-Ingram Cancer Center has initiated tumor mutation testing for a limited number of patients with metastatic colorectal cancer.